Celltrion Pharm Inc (068760) — Cash Flow Quality Index
Celltrion Pharm Inc (068760) has a Cash Flow Quality Index of 2.05x as of September 2025. Operating cash flow of ₩23.44 Billion exceeds net income of ₩11.46 Billion, indicating high earnings quality where cash backs reported profits. Explore cash flow conversion of Celltrion Pharm Inc to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Celltrion Pharm Inc Cash Flow Quality Index (2014–2024)
Historical Cash Flow Quality Index for Celltrion Pharm Inc across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Celltrion Pharm Inc (068760) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Celltrion Pharm Inc (2014–2024)
Year-by-year earnings quality comparison for Celltrion Pharm Inc. For live market cap and the full company financial profile, see Celltrion Pharm Inc (068760) market capitalisation.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 2.58x | ₩56.59 Billion | ₩21.97 Billion | ▲ +525.6% |
| 2023 | 0.41x | ₩8.76 Billion | ₩21.26 Billion | ▲ +364.2% |
| 2022 | -0.16x | ₩-4.05 Billion | ₩25.96 Billion | ▼ -105.8% |
| 2021 | 2.69x | ₩93.15 Billion | ₩34.58 Billion | ▲ +55.6% |
| 2020 | 1.73x | ₩36.25 Billion | ₩20.94 Billion | ▼ -46.5% |
| 2019 | 3.24x | ₩27.85 Billion | ₩8.60 Billion | ▲ +162.1% |
| 2016 | -5.22x | ₩-15.21 Billion | ₩2.92 Billion | ▼ -362.9% |
| 2015 | 1.98x | ₩13.36 Billion | ₩6.73 Billion | ▼ -32.8% |
| 2014 | 2.95x | ₩17.33 Billion | ₩5.87 Billion | — |